Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...
Kids who received oseltamivir during their flu-related hospitalization were 31% less likely to be admitted to the ICU ...
As we head deeper into fall and toward the holiday season, your little one may start to exhibit symptoms like a runny nose, ...
Tue, Oct 21, 2025 One of the UK's most stunning national parks was under bird flu alert after more than 10,000 poultry face ...
Visalia Times-Delta on MSN
Tulare veterinarian discovers promising avian flu treatment for cats
A new study of avian flu in cats focuses on a potentially life-saving discovery by veterinarian Dr. Jake Gomez, who treated four infected cats in Tulare.
Learn flu symptoms, how it spreads, when you’re contagious, plus testing, antivirals and annual vaccines, including high-dose ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Dear A.T.R.: Both colds and influenza (the "flu") are respiratory illnesses that are caused by viruses. Influenza is caused ...
Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price ...
Genentech plans to offer its flu medicine at a lower price through its first direct-to-patient program as the Trump administration pushes for more affordable U.S. drug prices.
The Food and Drug Administration has granted Breakthrough Therapy designation to CD388 for seasonal influenza prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback